Status:

ENROLLING_BY_INVITATION

Pain Resilience for Low Back Pain.

Lead Sponsor:

Integrative Pain Science Institute

Conditions:

Chronic Low Back Pain (CLBP)

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Chronic pain affects about 20% of adults in the U.S. and can lead to serious personal, social, and economic challenges. It is often treated with medications, including opioids, which carry risks of de...

Detailed Description

Chronic pain is pain that lasts beyond the typical healing duration, and is typically defined as lasting for at least 3-6 months. Approximately 20% of the adult U.S. population experiences chronic pai...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Adults experiencing chronic pain of any diagnosis for a duration of at least 6 months.
  • Ability to read and understand English.
  • Exclusion Criteria
  • Experiencing acute pain related to a recent injury or pain lasting less than 6 months.
  • Inability to read or understand English.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 31 2025

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT06971809

    Start Date

    October 1 2024

    End Date

    July 31 2025

    Last Update

    May 14 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Integrative Pain Science Institute

    New York, New York, United States, 10011